NCT00440388 2010-08-27Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's LymphomaAscenta TherapeuticsPhase 2 Completed23 enrolled
NCT00286780 2010-08-13Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic LeukemiaAscenta TherapeuticsPhase 2 Completed19 enrolled